Alternatives to Imagia EVIDENS

JADBio is an automated machine learning platform that uses JADBio's state-of-the art technology without any programming. It solves many open problems in machine-learning with its innovative algorithms. It is easy to use and can perform sophisticated and accurate machine learning analyses, even if you don't know any math, statistics or coding. It was specifically designed for life science data, particularly molecular data. It can handle the unique molecular data issues such as low sample sizes and high numbers of measured quantities, which could reach into the millions. It is essential for life scientists to identify the biomarkers and features that are predictive and important. They also need to know their roles and how they can help them understand the molecular mechanisms. Knowledge discovery is often more important that a predictive model. JADBio focuses on feature selection, and its interpretation.

Marketing solutions driven by data leverage a Customer Data Platform to enhance the optimization of consumers' purchasing journeys. By activating and utilizing first-party data, marketers can gain improved insight and transparency throughout their marketing and advertising processes. Develop precise user personas informed by demographics, behaviors, transaction records, and browsing habits, while also enhancing these groups with additional data layers. Oversee digital inventories across your own or partners' platforms to generate extra revenue or launch targeted campaigns. Integrate valuable information from various sources—whether online or offline, first-party, second-party, or third-party data. Employ this consolidated data perspective to craft effective digital strategies. Implement either existing or tailored Machine Learning models to formulate custom segments and audience cohorts, alongside predictive modeling and heuristics, thus ensuring that your marketing efforts are both strategic and impactful. This comprehensive approach not only boosts engagement but also fosters long-term customer loyalty.

Enhance your digital transformation journey while uncovering valuable insights from your data with customized health analytic solutions. Featuring an intuitive drag-and-drop interface, SAS Health Cohort Builder allows users to query and create cohorts based on temporal relationships without any coding skills necessary. This user-friendly tool enables easy exploration of cohort traits and the impact of various inclusion or exclusion criteria on patient groups, assisting in assessing the feasibility of studies. You have the capability to save cohort definitions for future use, modify them as needed, and apply them across different real-world data resources for comparative analysis, ultimately conserving both time and resources. Additionally, you can validate findings and conduct further analyses through in-memory processing and visualization in SAS or other platforms such as R, Python, and various third-party visualization applications. On the other hand, SAS Health: Episode Builder empowers you with the ability to view and modify episode definitions directly, ensuring that you have control over the process. With SAS’s fully documented logic to generate episodes of care, you can rest assured that the underlying business rules are both transparent and subject to audit at any time, further enhancing the reliability of your health data analytics. This combination of features positions SAS as a leading tool in the realm of health analytics.

At Genospace, we recognize that the evolution of precision medicine is being propelled by advancements in genomics, yet the challenge of effectively scaling its implementation remains unresolved. Our mission is to bridge this gap. Our innovative platform aims to transform biomedical data into valuable insights that are easily accessible for all, particularly for those actively involved in delivering care. Equip your clinicians and researchers with essential information that empowers them to make well-informed choices while participating in our goal of utilizing intricate molecular data to enhance patient outcomes and speed up the processes of drug development and research. In this context, the significance of large-scale population data for drug discovery and research cannot be overstated. Utilize cohort-driven analyses through the Genospace platform to support your research initiatives. We have a strong focus on clinical trial research, enabling the Genospace platform to seamlessly align fragmented patient information with intricate trial requirements, thus facilitating quicker patient recruitment. Furthermore, our platform is designed to integrate genomic medicine into standard clinical care practices, making it easier than ever to harness the power of genomics in everyday healthcare. Together, we can push the boundaries of what’s possible in patient care and research.

Clinithink stands out as a premier technology firm in the healthcare sector, focusing on artificial intelligence solutions that convert unstructured medical information into valuable insights. The company's proprietary CLiX platform leverages Clinical Natural Language Processing (CNLP) to decipher intricate clinical narratives, which empowers healthcare providers to improve both patient outcomes and operational productivity. Clinithink delivers customized solutions across various domains, including life sciences, revenue cycle management, and population health, effectively tackling issues such as identifying patient cohorts, maximizing reimbursement, and monitoring disease progression. With its cutting-edge technology, Clinithink has earned the confidence of top pharmaceutical and healthcare entities globally, establishing its leadership in the realm of healthcare AI and digital health progress. Moreover, the CLiX platform is adept at comprehending a wide array of unique and intricate clinical concepts, including but not limited to certainty, severity, laterality, and temporality, further enhancing its utility in clinical settings. As the demand for innovative healthcare solutions grows, Clinithink remains committed to advancing its technology to meet the evolving needs of the industry.

Transform your healthcare experience with the revolutionary Soliton® AI, which is powered by 30,000 evidence-based rules and advanced machine learning techniques. By automating various healthcare and care management functions, Soliton® equips you with the tools necessary to thrive in a value-based care environment, offering unmatched capabilities. It efficiently analyzes vast amounts of patient data in real-time, leading to enhancements in both clinical outcomes and financial performance, while also supporting a range of Alternative Payment Models (APMs). The solution boosts the effectiveness of telehealth by forecasting billable codes during patient interactions and predicting future healthcare costs through sophisticated risk stratification models. Furthermore, it provides timely clinical decision support to assist in managing intricate patient populations. Soliton® optimizes the patient journey, facilitating seamless transitions from acute to post-acute care through AI-driven care coordination. Moreover, it identifies care gaps, uncovers service and coding opportunities, and generates tailored patient assessments and personalized care plans, while also enabling the creation of custom cohorts for targeted interventions. As a result, Soliton® not only enhances operational efficiency but also elevates the overall quality of patient care.

BEKhealth provides an innovative clinical research platform, known as the BEKplatform, which leverages artificial intelligence to streamline the extraction, interpretation, and standardization of both structured and unstructured electronic medical record data, encompassing various elements such as lab results, diagnoses, physician notes, pathology reports, and PDFs. This integrated system creates a searchable, longitudinal patient graph designed to assist life sciences and healthcare organizations in swiftly pinpointing protocol-eligible patients while enhancing trial feasibility, site selection, and recruitment processes. By utilizing advanced deep learning techniques and natural language processing, BEKhealth transforms chaotic clinical data into precise, actionable insights, allowing for the generation of sophisticated queries and patient cohorts. This method not only identifies more qualified candidates compared to traditional manual chart reviews but also provides real-time reports and dashboards that facilitate informed decision-making across research networks, ultimately improving the efficiency and effectiveness of clinical trials. The ability to generate these insights in real-time is a game-changer for organizations striving to maximize their research potential.

Altis Labs has unveiled Nota, a groundbreaking clinical information platform designed to expedite therapeutic research and development. By harnessing the power of AI, Nota can forecast patient outcomes based on imaging data, allowing sponsors to efficiently prioritize their most promising therapies. This innovative platform empowers researchers to effectively utilize clinical trial imaging data, gain access to predictive imaging biomarkers, and enhance R&D efforts on a larger scale. With Altis’ cloud-based software, which employs advanced deep learning techniques, biopharma companies can integrate detailed outcome predictions at the image, patient, and cohort levels, ultimately refining clinical trial design and boosting confidence in anticipating clinical endpoints. The insights generated by Nota have the potential to drastically shorten development timelines, reduce drug development expenses, and increase the chances of success across various therapeutic areas, paving the way for a new era in clinical research. As the demand for efficient drug development continues to rise, Nota stands out as a vital tool for the biopharmaceutical industry.

Pearl's innovative platform, powered by artificial intelligence, empowers healthcare teams to cut unnecessary expenses, enhance patient outcomes, and thrive in value-based care by pinpointing priority patients and encouraging timely interventions while seamlessly fitting within existing workflows without causing disruption. This technology merges predictive analytics with effective action; it emphasizes significant outreach and automates subsequent steps, evaluates provider readiness and cohort risk to align participants with suitable payment models, and links intelligence to action to foster measurable advancements in clinical, financial, and operational performance. Moreover, it integrates flawlessly into provider systems, enabling teams to deliver high-quality care on a large scale. The platform's advanced data-science and actuarial capabilities maximize savings, improve benchmarks, and support various models like ACO REACH, MSSP, and Medicare Advantage, all while equipping physicians with user-friendly tools that streamline care delivery, alleviate them from mundane tasks, and enhance management of patient panels. Ultimately, Pearl's solution stands out in the healthcare landscape by prioritizing efficiency and effectiveness in care delivery, ensuring that both providers and patients benefit from its comprehensive features.

The Veradigm Real-World Evidence (RWE) analytics platform is an economical software-as-a-service solution designed for the clear and efficient analysis of real-world data. This platform is utilized by organizations in life sciences and clinical research to delve into electronic health records (EHR) data comprehensively. Adhering to OMOP standards, the analytical platform enhances the efficiency and reliability of generating real-world evidence. By leveraging the Veradigm Network data, users can execute population analyses in mere minutes, build reusable patient cohorts with consistent terminology across various data sources, and facilitate repeatable retrospective studies. Additionally, the platform supports analysis on any dataset that fits within the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM), including those sourced from Veradigm Network EHR Data. Overall, this powerful tool is designed to streamline research processes and enhance the quality of insights derived from real-world data.

Combine and liberate your disorganized health information through an interactive AI and NLP solution that provides valuable health insights for various stakeholders. This innovative technology serves Providers by hastening the data abstraction process and ensuring the clinical information validation found within notes, thus minimizing the time and costs associated with identifying care gaps, assessing the quality of care through dashboards, and producing registry reports. For Payers, it facilitates the integration and analysis of claims alongside clinical notes, enhancing the management of high-risk and high-cost member populations. In the realm of Life Sciences, this solution enables swift patient matching to clinical trials using databases alongside clinical note data, maximizing the potential of real-world clinical evidence. Ember offers a comprehensive approach that merges NLP with predictive analytics, streamlining healthcare analytics for unstructured data to boost quality, efficiency, and outcomes in the healthcare system. As a result, stakeholders can make informed decisions that lead to improved patient care and resource allocation.

Engage with a medical-focused generative AI that not only elucidates its responses but also cites relevant references, refreshes its medical knowledge on a daily basis, and allows users to personalize and select knowledge bases. This AI comes equipped with a pre-loaded database and has been trained using over 2,300 reference datasets put together by experts in the medical field, encompassing a wide array of terminologies, medical research, clinical trials, patents, population health insights, costs, as well as public and regulatory information. It indexes numerous sources of medical research and data, ensuring a comprehensive understanding of the available information. The system is designed to receive daily updates on the latest medical findings, clinical trial results, and evolving terminologies, making it capable of processing vast quantities of documents, potentially reaching into the millions or billions. Moreover, the cluster can be scaled according to specific requirements. As a type of conversational AI, a medical chatbot employs natural language processing (NLP) technologies to communicate with users, delivering valuable medical information, guidance, or assistance. These chatbots serve various functions, including addressing general inquiries regarding diseases, health concerns, and available treatment options, thus enhancing the accessibility of medical knowledge for users everywhere.

Sano Genetics delivers a comprehensive 360° platform designed for precision medicine and clinical trial research, integrating various aspects such as patient recruitment, genetic testing, informed consent, and ongoing engagement to significantly enhance and streamline study processes. The platform accommodates custom protocol creation and the preparation of ethical submission documents, alongside digital prescreening and consent procedures, as well as recruitment assistance through online marketing efforts, partnerships, and advocacy groups, which allows sponsors and contract research organizations to connect with specific patient populations or those often overlooked in various regions. Additionally, Sano provides convenient, non-invasive saliva-based DNA testing kits that serve as a budget-friendly option compared to traditional clinic blood draws, along with logistical support for sample collection and processing. Their services include dependable genetic and biomarker analysis conducted by accredited laboratories, bioinformatics services, and the return of results, complemented by genetic counseling when necessary, ensuring a holistic approach to patient care and study accuracy. By leveraging technology and community engagement, Sano Genetics is poised to transform the landscape of clinical trials and personalized medicine.

Panalgo’s Instant Health Data platform is an all-encompassing software suite for healthcare analytics designed to simplify programming complexities and expedite the analysis of real-world data across various sectors, including life sciences, pharmaceuticals, payers, providers, government, and academia. This platform assimilates a wide range of health data sources—such as claims, electronic health records, registry information, and other real-world datasets—and transforms them into a cohesive, analysis-ready format using a healthcare-specific data model alongside a rich library of algorithms. This enables fast, scalable, and clear analytics without the conventional barriers of coding. Users can benefit from point-and-click analytics, personalized dashboards, statistical assessments, machine learning predictions, automated documentation, and collaborative reporting, empowering stakeholders to efficiently investigate, interpret, and disseminate insights. Additionally, integrated features like Ella AI offer natural-language, generative-AI support that assists in cohort building, insight generation, and decision-making processes, further enhancing the platform's utility for its users. As a result, Panalgo’s IHD not only streamlines analytics but also fosters a collaborative environment for various healthcare stakeholders.

Enhance the effectiveness of antimicrobial use in hospitals by equipping prescribers and Antimicrobial Stewardship Program (ASP) members with our innovative AI-driven software, ZEVAC. The challenge of antibiotic resistance represents a critical public health concern today. ZEVAC is an advanced AMS software harnessing the power of AI to assist hospitals in eliminating unnecessary or improper antibiotic prescriptions. It employs a scientific yet unconventional methodology in combating the rise of antimicrobial resistance (AMR). By utilizing ZEVAC, clinicians can access precise and tailored antibiotic susceptibility predictions, which are informed by patient demographics, clinical details, local hospital prevalence, susceptibility trends, and historical culture data. In addition, ZEVAC empowers ASP members by providing proactive strategies to prevent inappropriate antimicrobial use through its real-time analysis of comprehensive hospital clinical data, ultimately fostering a more responsible approach to antibiotic stewardship. This multifaceted approach not only aids in individual patient care but also contributes to the broader goal of preserving antibiotic efficacy for future generations.

PYCAD is a company that focuses on artificial intelligence solutions specifically for medical imaging and computer vision. With a background of more than three years in medical imaging expertise and six years in computer vision, PYCAD provides a range of services that encompass data management, model training, and deployment. Their offerings include assisting clients with data preparation through annotation support, anonymization, and format management, thus ensuring that data is primed for both analysis and model training. PYCAD carefully chooses the best model configurations suited for distinct tasks and takes charge of the entire training process, resulting in the creation of high-performance models. In addition to this, the company deploys these trained models as APIs on cloud platforms such as Google Cloud Platform (GCP) or Amazon Web Services (AWS) and develops MVP user interfaces for smooth integration into existing systems. Since its inception in 2023, PYCAD has successfully executed over ten projects, working collaboratively with clients to fully grasp their requirements and deliver effective solutions. The company places a strong emphasis on maintaining data privacy and security, ensuring that all client data remains confidential and is permanently deleted after project completion. This commitment to client satisfaction and data integrity helps to build lasting relationships with their partners.

CareJourney is an advanced healthcare analytics platform hosted in the cloud, providing extensive and clinically relevant insights derived from one of the largest longitudinal claims datasets in the United States, encompassing hundreds of millions of beneficiaries from Medicare, Medicaid, Medicare Advantage, and commercial sectors, while also profiling over 2 million healthcare providers. This platform enables organizations to evaluate markets and patient groups to discover opportunities for cost efficiency and improved health outcomes, facilitate the development and enhancement of high-performing networks, make informed contracting choices, identify referral trends and service leakage, and compare provider performance with that of their peers. Moreover, it aids in managing at-risk populations by utilizing segmentation models that allow organizations to gain valuable insights into the prevalence of chronic conditions, patterns of care utilization, and the factors driving costs. The comprehensive data analysis provided by CareJourney ultimately supports organizations in achieving their healthcare goals more effectively.

PeriopSim is an innovative medical simulation training tool tailored for perioperative nurses and surgical teams, enabling them to safely familiarize themselves with instruments and procedures prior to actual surgeries. This application features comprehensive step-by-step instructions accompanied by authentic surgical footage and voice guidance, creating an immersive learning experience. Its primary goal is to shorten the orientation period for novice nurses, equipping them with the knowledge they need before stepping into the operating room, which subsequently boosts their confidence when handling unfamiliar surgical tasks. Moreover, PeriopSim offers extensive analytics reports that monitor both individual and group learning trajectories, facilitating effective training while promoting cost-efficiency through the secure sharing of iPads among various student groups, teams, or departments. The development and validation of PeriopSim involved collaborative research with surgeons, nurses, and educators, and it has gained traction, being implemented in over 200 healthcare facilities across the nation. This widespread adoption underscores the application's effectiveness in enhancing the training experience for surgical staff.

GenHealth.ai is a specialized generative AI platform designed for the healthcare sector, utilizing a unique Large Medical Model (LMM) developed from the analysis of over 100 million patient records instead of traditional natural language data. This LMM excels in interpreting medical codes and events, allowing it to accurately forecast patient outcomes, estimate costs, and model clinical pathways with significantly fewer errors compared to conventional large language models. The platform features a range of tailored applications such as Intake Automation for managing PDF routing and data extraction, a Prior Authorization Agent that automates the approval process, and G‑Mode analytics that allows users to interact with both historical and predictive population health data using natural language, all without requiring any coding expertise. Notably, this AI co-pilot has achieved an impressive 94% accuracy rate in prior authorization cases, a remarkable 120-fold enhancement in forecasting medical loss ratios, and a 110% improvement in cost predictions when compared to standard Hierarchical Condition Category (HCC) scoring methods. In addition to these advancements, GenHealth.ai is positioned to transform the healthcare landscape by facilitating more efficient and data-driven decision-making.

Savana is a clinical intelligence platform that utilizes artificial intelligence to convert unstructured text from electronic medical records into valuable real-world evidence through sophisticated natural language processing techniques. Launched in 2014, Savana has facilitated the structuring and examination of billions of clinical documents in various languages and regions, revealing insights that were previously obscured within healthcare data. Its EHRead NLP models drive tools for anonymization and pseudonymization, effectively managing both structured and unstructured data on a large scale, having processed over 35 million documents to date. By providing hospitals, researchers, and health systems with actionable, research-grade evidence, Savana supports precision medicine initiatives, conducts epidemiological studies, including predictive analyses related to COVID-19, and enhances broader clinical data strategies, solidifying its position as one of Europe's leading contributors to Health Economics and Outcomes Research (HEOR). Additionally, Savana's innovative approach continues to reshape the landscape of data analysis in healthcare, promoting more informed decision-making that can ultimately improve patient outcomes.

Alife’s advanced AI software is designed to enhance clinic operations, leading to better patient outcomes, greater efficiency, and an improved overall experience for patients. The Alife Assist platform is customizable to support clinic staff in making informed decisions based on data analysis. By integrating smoothly with electronic medical records (EMR), Alife’s AI swiftly transforms raw data into practical insights. It also aims to maximize the retrieval of mature oocytes from ovarian stimulation cycles. This suite of products is created to empower all clinic personnel, ensuring that every team member can contribute effectively. Furthermore, it standardizes the embryo grading process while enhancing quality control and record management. Real-time monitoring of clinic key performance indicators (KPIs) boosts operational efficiency, saving valuable time and reducing costs. Research indicates that interpretable machine learning models perform comparably to embryologists when it comes to selecting optimal embryos for IVF transfer, showcasing their potential utility in clinical settings. Additionally, the study highlights that AI-driven insights might assist in fine-tuning the timing of ovulation trigger injections, potentially leading to improved outcomes for patients undergoing IVF treatments. Overall, this innovative approach represents a significant leap forward in reproductive health technology.

Validcare transforms the conventional clinical trials approach by overseeing every phase from study design to result delivery. By broadening access to a wider range of patients, Validcare enhances the focus on patient-centered research. The streamlined participation process allows patients to share richer data, which in turn boosts data collection and integrity for researchers. Additionally, Validcare creates a stronger link between patient feedback and product development, facilitating real-time insights that expedite clinical research. This innovative approach not only ensures higher quality evidence but also enhances the likelihood of completing studies on schedule, ultimately benefiting both patients and researchers alike.

OM1 leverages artificial intelligence and extensive clinical data to significantly enhance research productivity and clinical decision-making via high-performance predictive models. The OM1 Patient Finder employs advanced AI technology seamlessly integrated with the OM1 Real-World Data Cloud. By merging various aspects of patient journeys from diverse data sources, it effectively identifies individuals most likely to be affected by the target condition. We have developed an intelligent data cloud that allows various healthcare stakeholders to access, analyze, and utilize outcomes data in a manner that is not only more comprehensive but also clinically relevant and precise. This enables rapid, accurate, and cost-effective access to research-grade insights regarding effectiveness, value, and safety. Moreover, it allows for the quantification of outcomes, facilitating the demonstration of value in risk-sharing and outcomes-based payment models. As a result, healthcare providers can make informed decisions grounded in real-world evidence.

RedBrick AI serves as a rapidly collaborative platform for annotating medical data, specifically designed to assist healthcare AI teams in creating high-quality training datasets across various types of radiological imagery, including CT, MRI, X-ray, Ultrasound, Fluoroscopy, and additional standard imaging techniques. The platform is adept at managing intricate tasks such as multi-series annotation and extensive DICOM studies, thanks to its native compatibility with medical data formats including DICOM and NIfTI. Furthermore, it boasts cutting-edge, user-friendly 2D and 3D web-based annotation tools, complemented by a PACS-like viewer. RedBrick AI supports a wide array of annotation use cases, including instance and semantic segmentation, landmark identification, classification, and ROI measurements, thereby enhancing the speed of annotation processes by as much as 60%. This significant improvement in efficiency can empower healthcare professionals to focus more on patient care rather than on time-consuming data preparation tasks.

Gesund stands as the pioneering compliant AI factory dedicated to facilitating the introduction of clinical-grade AI solutions into the market. In order to meet regulatory standards, our platform meticulously audits and validates third-party medical AI solutions, ensuring their safety, effectiveness, and fairness. Gesund seamlessly manages the entire AI/ML lifecycle for all participants by integrating models, data, and expertise within a user-friendly no-code environment. We offer standardized, cohesive, and diverse data tailored to meet your machine learning requirements and regulatory obligations. By evaluating the validation needs of models, Gesund.ai supplies an optimal combination of high-quality data sourced from its extensive network of clinical partners. Model owners can share their clinical studies with Gesund.ai to curate the necessary datasets, subsequently uploading their models onto Gesund.ai's federated validation platform, which can be situated on hospital premises or within a private cloud. Each model undergoes evaluation against a validation dataset that has been specifically curated on the hospital side, ensuring that the results are relevant and reliable, ultimately enhancing the quality of healthcare solutions. Through this comprehensive approach, Gesund not only supports compliance but also accelerates the path to effective AI deployment in clinical settings.

VIPER streamlines the process of screening by automating remote patient identification right at the diagnosis stage and ensuring qualified enrollment. By leveraging artificial intelligence, VIPER efficiently matches patients to precision trials during a critical enrollment period by utilizing lab-agnostic genomic data, electronic medical records (EMR), and pathology information tailored to both the patient and the research requirements. The system employs a specialized matching engine that searches for the most suitable clinical trials corresponding to a patient's specific diagnosis at the moment they receive it. Additionally, through seamless workflow integration, VIPER provides real-time alerts regarding a patient’s eligibility for available trials, ensuring the entire care team is informed during this narrow enrollment timeframe. Furthermore, VIPER features interactive dashboards that offer extensive data mining capabilities, allowing for the aggregation of site and study-level patient data to effectively meet study key performance indicators (KPIs). This comprehensive approach not only enhances trial recruitment efficiency but also supports researchers in achieving their goals more effectively.

VideaAI is an innovative platform that leverages artificial intelligence to enhance the precision of diagnostics, streamline clinical processes, and boost operational productivity in dental practices by examining dental imaging alongside practice data. Utilizing sophisticated machine learning algorithms that have been developed with extensive datasets of dental images, it is capable of automatically scrutinizing common radiographs, including bitewing and panoramic X-rays, to uncover clinical issues such as cavities, bone degeneration, and other oral health concerns that may not be easily visible to the unaided eye. The platform effectively conveys these clinical findings through intuitive visual overlays and annotations, aiding dentists in communicating diagnoses to patients and fostering a clearer understanding of proposed treatment options. VideaAI seamlessly integrates with current dental imaging systems and practice management tools, providing AI-driven insights in real time at the point of care, all while maintaining the flow of clinical operations. Additionally, by enhancing both diagnostic capabilities and patient engagement, VideaAI positions dental practices for improved outcomes and overall patient satisfaction.

Discover the transformative online learning journey at upGrad, where the finest minds from both industry and academia converge to offer unparalleled mentorship, robust support, and intensive career guidance. Dive deep into essential concepts taught by esteemed faculty specializing in data, technology, and management, and take pride in joining the ranks of alumni from top-tier universities recognized by various industries. Participate in engaging on-campus BaseCamps, hackathons, and memorable graduation events that enhance your educational experience. Maintain your academic momentum with the assistance of a dedicated personal student success mentor, who ensures you have access to all necessary resources. Benefit from real-time support and answers to your questions through a community of academic fellows available via live sessions and discussion forums. Collaborate and build connections with fellow students in your cohort, engaging in projects and case studies sourced from leading companies in the fields of data, technology, and digital innovation. Tackle real-world challenges by participating in sponsored projects and hackathons, equipping yourself with hands-on experience that will set you apart in the job market. This comprehensive approach not only enhances your skills but also prepares you for a successful career ahead.

Affinity Answers merges extensive behavioral insights with the largest social dataset globally to validate online activities including browsing, e-commerce, searches, and mobile intent, leading to the creation of custom audiences that surpass purchase-based segments by an impressive average of 55%. Users can specify their target criteria, including desired audiences, timelines, geographic locations, channels, and budget, and will receive tailored audience definitions that come with targeting filters, estimated reach, and unique intent scores within just 1 to 2 business days; after approval, these audiences can be activated on demand-side platforms such as DV360 and The Trade Desk within a span of 7 to 10 days. This system is capable of generating an infinite variety of persona-level segments, including competitive conquest groups (for instance, customers of competitors to USAA), psychographic cohorts (like followers of prominent influencers), groups showing purchase intent (such as enthusiasts of bacon), and audiences focused on topical news (such as readers of political news), all accessible through either an API or a user-friendly web interface. The versatility of Affinity Answers empowers marketers to create highly specialized segments tailored to their specific needs.

Our platform offers a web-based interface designed for the efficient collection of data from various types of studies and clinical scenarios. Thanks to its adaptable and user-friendly data entry methods, data can be tailored to suit any medical specialty, patient demographic, or research initiative. The system enhances care quality by monitoring patient-reported outcomes and leveraging population analytics. Its secure, web-based design ensures compatibility with both personal computers and tablets, facilitating seamless data input. Researchers benefit from real-time reporting capabilities, enabling them to oversee the complete study process for both single and multi-site research, independent of their geographical settings. The DADOS Platform features an exceptional user interface (UI) and intuitive tools that empower clinicians and researchers to design programs or studies that effectively connect research and clinical practice. Patients find DADOS appealing due to its straightforward usability and accessibility from anywhere, making it a valuable tool in modern healthcare. Ultimately, this innovative platform fosters a collaborative environment where research and patient care can thrive together.

Regardless of whether you are a training organization, content provider, or a large enterprise, CALF enables you to implement your training efficiently and on a large scale. Featuring cutting-edge mobile applications and an engaging user interface, CALF empowers you to craft your educational experiences effortlessly, allowing for customized learning paths that enhance user interaction and facilitate ongoing feedback. The acronym CALF represents Continuous Application of Learning Feedback, emphasizing the intrinsic link between feedback and effective learning. Uniquely, CALF incorporates the Kirkpatrick Model of Training Effectiveness, making it the only platform in the world to do so. With CALF, you can showcase your learning impact, whether it be in business or social contexts, all while designing your educational pathways according to your specific needs, which may include training sessions, coaching, assessments, or surveys. You can efficiently manage numerous groups and clients simultaneously, receiving real-time updates on participant progress. Furthermore, CALF provides the flexibility to deliver your programs in a variety of formats, including instructor-led, self-paced, or blended approaches, ensuring that you can meet diverse learning preferences effectively. Embrace the future of learning with CALF and transform how you engage with your audience.

Harnessing cutting-edge open-source AutoML technology, we facilitate the creation of high-quality models effortlessly. This system incorporates Deep Learning and pre-trained models to enhance intelligence wherever relevant. By employing Causal AI alongside AutoML, it ensures fairness, supports causal inference, and provides counterfactual predictions. Each trained model can be deployed instantly for interactive online use or through an API, making it accessible to all users. Additionally, it offers comprehensive insights into feature importances and model explanations through Shapley values. Our AI engine operates entirely on an open-source framework, allowing for complete transparency and universal applicability of our algorithms. It effectively groups customers or products into similar cohorts based on an extensive array of features. Furthermore, it predicts future outcomes by identifying temporal patterns in historical data and is capable of training predictive models using labeled data to make predictions on unlabeled datasets, thereby enhancing its overall utility and performance.

Simsurveys is an innovative platform that leverages artificial intelligence to create synthetic survey data and market research panels in a matter of minutes, significantly reducing the time usually required for such tasks. By utilizing AI models that are informed by real population studies, it generates detailed respondent-level datasets that reflect accurate demographic, behavioral, and attitudinal characteristics. Users can craft complex questionnaires complete with specific quotas and logical flows, instantly producing large samples of synthetic respondents and easily exporting these datasets for further analysis, thus eliminating the usual reliance on recruiting actual participants or integrating various tools. The platform offers capabilities for generating synthetic data from the ground up, enhancing sample sizes, and addressing demographic shortcomings, while also providing real-time queries through an API that delivers probability-weighted distributions for immediate consumer insights. Additionally, Simsurveys facilitates AI-moderated qualitative sessions, allowing for a seamless integration of both quantitative and qualitative research methodologies to enhance the depth of insights gathered. This combination of features makes Simsurveys a robust solution for modern market research needs.

SyntheticIQ is an innovative platform focused on synthetic intelligence research and strategy, enabling organizations to derive actionable insights by creating and analyzing virtual synthetic human populations, known as “Synths,” that closely resemble real-world target demographics for more efficient and cost-effective decision-making. Users have the capability to customize these Synth populations based on specific characteristics, traits, and behaviors, allowing them to design dynamic studies and strategy simulations to evaluate messaging, campaign effectiveness, hypotheses, policies, and strategic options with data that reflects actual responses. The platform also features tools such as Synth Creator, which assists in defining target personas, the IQ Study Builder for conducting interactive research simulations and surveys with Synth groups, and IQ Insights that compiles the findings into comprehensive, user-friendly reports that aid in swiftly refining tactics and enhancing strategic decisions. Additionally, this holistic approach fosters an environment where organizations can experiment and iterate on their strategies with a high degree of confidence.

The initial groups we launched filled up in mere hours. Sign up now to be added to the waitlist and guarantee your place in the upcoming cohort. Do you possess valuable insights to offer but feel uncertain about how to begin? Many content creators find themselves daunted by the multitude of factors, unforeseen challenges, and the extensive effort required to develop a multifaceted digital product like a cohort-based course. This is precisely why Maven is now open for applications to our latest cohort-based course titled How to Build a Cohort-Based Course (it's quite the concept). Our program is designed to enable anyone to participate without having their course ready yet, ensuring you’ll have a polished course to unveil by the end of six weeks. As a fully remote company, we are in the process of gathering a remarkable team of skilled individuals to transform online education. We are currently on the lookout for our inaugural engineers as we prepare to launch courses featuring an exceptional lineup of early instructors. Explore our available job openings and consider joining us on this exciting journey.

Utilizing only real data presents notable obstacles in the training of machine learning models. In contrast, synthetic data offers boundless opportunities for training, effectively mitigating the limitations associated with real datasets. Enhance the efficacy of your geospatial analytics by generating the specific imagery you require. With customizable options for satellite, drone, and aerial images, you can swiftly and iteratively create various scenarios, modify object ratios, and fine-tune imaging parameters. This flexibility allows for the generation of any infrequent objects or events. The resulting datasets are meticulously annotated, devoid of errors, and primed for effective training. The OneView simulation engine constructs 3D environments that serve as the foundation for synthetic aerial and satellite imagery, incorporating numerous randomization elements, filters, and variable parameters. These synthetic visuals can effectively substitute real data in the training of machine learning models for remote sensing applications, leading to enhanced interpretation outcomes, particularly in situations where data coverage is sparse or quality is subpar. With the ability to customize and iterate quickly, users can tailor their datasets to meet specific project needs, further optimizing the training process.

Our platform, designed with regulatory compliance in mind, enhances clinical research by using algorithms to sift through unstructured EMR data to identify life-threatening conditions. We create cutting-edge technologies that broaden access to groundbreaking healthcare solutions through Clinical Trials. Our dedicated team is committed to saving lives by facilitating access to therapeutic innovations that are still being researched. We strongly advocate that every patient should be informed and empowered regarding their potential to engage in clinical trials that could offer significant therapeutic benefits. As a forward-thinking healthcare AI research firm, we have created a computational platform that identifies patients who meet a detailed set of criteria for participation in clinical trials, ensuring that the most suitable candidates are considered for these critical studies. Through our work, we aim to revolutionize the way patients connect with life-changing treatment opportunities.

Discover a wealth of benefits for any organization. From the largest offer of educational opportunities in Europe to the highest ROI per employee. With our background as learning consultants, we know exactly where the challenges in the marketplace lie. Learning should be fluid, because everyone has different learning needs. There is no one size fits all approach. We always try to think a little bit ahead. We provide a learning platform that is future-proof and empowers employees and organizations with innovative and creative solutions. Platform capabilities: Compliance Management and Certificates Assessment/survey tool built in Authoring tool built-in Cohort-based learning (Cohorts can share any type of material with other members) Create as many communities/learning pods you want Content Curation E-Learning Marketplace Event Management Gamification Integration with other platforms and systems Modern UI/UX Multi-Tenant/Extended Enterprise Physical Training (ILT/VILT). Automated notifications Skill taxonomy, metrics and skill levels

ConcertAI stands out as a prominent provider of AI-driven solutions within the healthcare sector, particularly in the field of oncology. Their core mission revolves around enhancing patient outcomes and expediting insights by leveraging top-tier real-world data, cutting-edge AI technologies, and deep scientific knowledge. The company presents an array of products and services aimed at improving both clinical research and patient care experiences. Their Real-World Data Products deliver extensive, customized datasets that cater to diverse research needs across various enterprises. By simplifying clinical trial processes, their digital trial solution ensures efficiency, while the Clinical Trial Optimization (CTO) platform employs extensive AI capabilities to refine the design and implementation of trials specifically in oncology and hematology. Additionally, in partnership with NeoGenomics, ConcertAI has introduced CTO-H, a software-as-a-service (SaaS) solution that concentrates on hematological malignancies, providing sophisticated research analytics and optimizing operational workflows. This integration of advanced technologies not only enhances research capabilities but also significantly contributes to the advancement of patient care in complex medical fields.

Verana Health operates as a platform for real-world data that converts both structured and unstructured information from electronic health records into curated, de-identified, disease-focused data modules through its clinician-informed and AI-enhanced VeraQ population health data engine. By aggregating data from key collaborations with prominent medical registries, including the American Academies of Ophthalmology, Neurology, and Urological Association, the platform integrates insights from over 20,000 clinicians and approximately 90 million patient records, thereby supplying high-quality datasets in near real-time for the purposes of generating real-world evidence, identifying clinical trial sites and subjects, reporting clinician quality, and managing medical registries. Users can access this wealth of information through cloud services like AWS Data Exchange and Amazon Redshift, which provide self-service API access, a user-friendly dashboard, and tools for customizable cohort discovery. Furthermore, the system employs advanced AI and machine learning algorithms along with comprehensive data quality assessments to ensure the reliability and accuracy of the information provided. This innovative approach not only facilitates efficient data utilization but also enhances the overall quality of healthcare research and practice.

At Enlitic, we believe that the power of artificial intelligence can transform healthcare by enabling effective data management and improving clinical workflows. Our mission at Enlitic is to intelligently manage healthcare data using the power of artificial intelligence to expand capacity and improve clinical workflows and create a foundation for a real-world evidence medical image database for healthcare providers. Through our Enlitic Framework, we aim to reimagine healthcare intelligence, enabling healthcare professionals to make informed decisions and provide personalized care to every patient.

AI-Enhanced Clinical Automated with Enterprise-Level Compliant: Our platform uses AI models such as OpenAI’s GPT-432K and BioClinical BERT which have been extensively researched and recognized for their clinical performance by premier scientific journals.

MedAffairs AI is a cloud-based machine learning tool empowered by artificial intelligence, specifically crafted to optimize the Medical Affairs sector within the pharmaceutical industry. Leveraging an extensive repository of medical affairs information, it delivers quick and precise answers to inquiries, thereby minimizing the time users spend sifting through various drives and folders. This innovative platform facilitates the smooth incorporation of internal materials such as clinical trials, standard operating procedures, and articles, allowing users to easily obtain answers by querying their uploaded documents. Each answer provided is linked to the relevant source document, ensuring straightforward referencing. Furthermore, MedAffairs AI enables searches of both internal and external data, offering thorough insights into medical knowledge, regulatory compliance, engagement with key opinion leaders, as well as the formulation and planning of medical strategies. In this way, the tool not only saves time but also enhances the efficiency of the Medical Affairs team in their decision-making processes.

newLab Cloud serves as a laboratory management platform optimized for AI and is constructed on the ServiceNow framework. It is specifically tailored to assist biotech, pharmaceutical, and research entities in optimizing their workflows, overseeing laboratory instruments, and automating compliance tasks. This platform is engineered for contemporary research and development settings, providing a comprehensive solution that includes equipment monitoring, document organization, workflow automation, and detailed audit trails, all within a secure cloud environment. Additionally, through its integrations with ServiceNow, newLab Cloud enhances the synergy between laboratory and IT operations, fostering better collaboration, safeguarding data integrity, and speeding up the pace of innovation across various sectors.

Houseware provides an additional dimension of revenue insight for your data warehouse. By linking your current data infrastructure or various SaaS applications, you can access ready-made metrics and entities. You have the flexibility to create user segments and cohorts while selecting from over 30 predefined blocks and templates to unlock revenue potential. Team collaboration allows you to effortlessly distribute a well-balanced mix of personalized campaigns, internal alerts, and notifications, all without the need for coding. Our team, composed of athletes, challenges the typical startup analogy that equates the journey to a marathon. Instead, we prepare for a marathon with the understanding that we will face multiple sprints along the way, each sprint feeling like a marathon in itself. This unique perspective encourages resilience and adaptability in our approach to growth and innovation.